Literature DB >> 8576887

Aggressive angiomyxoma of the pelvis and perineum. A case report.

A Fishman1, L P Otey, A N Poindexter, R L Shannon, R E Girtanner, A L Kaplan.   

Abstract

BACKGROUND: Aggressive angiomyxoma of the female perineum and pelvis is a slowly growing neoplasm occurring almost exclusively in women of reproductive age. The tumor is characterized by its locally infiltrative behavior. The high recurrence rate has been attributed to incomplete surgical excision. CASE: A case of a huge, recurrent, aggressive angiomyxoma of the perineum and pelvis was treated.
CONCLUSION: Correct preoperative diagnosis and assessment of simultaneous perineal and pelvic involvement indicate a combined abdominoperineal surgical approach to achieve wide, tumor-free margins.

Entities:  

Mesh:

Year:  1995        PMID: 8576887

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

Review 1.  Aggressive angiomyxoma of the vulva in pregnancy: a case report and review of management options.

Authors:  Rashmi Bagga; Anish Keepanasseril; Vanita Suri; Raje Nijhawan
Journal:  MedGenMed       Date:  2007-01-24

2.  Aggressive Angiomyxoma with massive ascites.

Authors:  Peihai Zhang; Kun Song; Li Li; Feng Geng; Jie Li; Ruifen Dong; Tingguo Zhang; Beihua Kong
Journal:  Gynecol Oncol Case Rep       Date:  2011-09-16

3.  Recurrent aggressive angiomyxoma of the vulva - a rare presentation.

Authors:  Sandip Kumar Sengupta; Sanjay Kumar Bhattacharyya; Shyama Prasad Saha; Hironmoy Roy; Amarendra Nath Sarkar
Journal:  J Clin Diagn Res       Date:  2014-05-15

4.  A Case Report of Aggressive Angiomyxoma in Pregnancy: Do Hormones Play a Role?

Authors:  Theofano Orfanelli; Chi-Son Kim; Sally F Vitez; James Van Gurp; Neeti Misra
Journal:  Case Rep Obstet Gynecol       Date:  2016-11-15

Review 5.  Aggressive angiomyxoma in pregnancy: a case report and literature review.

Authors:  Haihua Xu; Pengming Sun; Rongli Xu; Lihua Wang; Yuequan Shi
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.